BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8765420)

  • 1. Role of glycoprotein 130 and c-Kit signaling in proliferation and differentiation of human hematopoietic progenitor cells.
    Nakahata T; Sui X; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Tsuji K
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S64-8. PubMed ID: 8765420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
    Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
    Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic action of Flt3 and gp130 signalings in human hematopoiesis.
    Ebihara Y; Tsuji K; Lyman SD; Sui X; Yoshida M; Muraoka K; Yamada K; Tanaka R; Nakahata T
    Blood; 1997 Dec; 90(11):4363-8. PubMed ID: 9373247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
    Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
    Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y
    Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells.
    Sui X; Tsuji K; Tajima S; Tanaka R; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Mar; 183(3):837-45. PubMed ID: 8642288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein 130 and c-kit signals synergistically induce thrombopoietin production by hematopoietic cells.
    Matsui A; Sato T; Maekawa T; Asano S; Nakahata T; Tsuji K
    Int J Hematol; 2000 Dec; 72(4):455-62. PubMed ID: 11197211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice.
    Peters M; Schirmacher P; Goldschmitt J; Odenthal M; Peschel C; Fattori E; Ciliberto G; Dienes HP; Meyer zum Büschenfelde KH; Rose-John S
    J Exp Med; 1997 Feb; 185(4):755-66. PubMed ID: 9034153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP130 and c-kit signalling, initiated by the sIL-6R/IL-6 complex, is insufficient to expand the primitive adult bone marrow CD34+CD38- pre-CFU cell.
    Van Bockstaele DR; Nijs G; Lenjou M; Bosmans E; Vanham G; Rodrigus I; Berneman ZN
    Ann Hematol; 2000 Dec; 79(12):667-71. PubMed ID: 11195003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cord blood transplantation and ex vivo expansion of hematopoietic stem cells].
    Nakahata T
    Rinsho Byori; 1999 May; Suppl 110():54-62. PubMed ID: 10475032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells.
    Kinoshita T; Sawai N; Hidaka E; Yamashita T; Koike K
    Blood; 1999 Jul; 94(2):496-508. PubMed ID: 10397717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and the soluble interleukin-6 receptor induce stem cell factor and Flt-3L expression in vivo and in vitro.
    Peters M; Solem F; Goldschmidt J; Schirmacher P; Rose-John S
    Exp Hematol; 2001 Feb; 29(2):146-55. PubMed ID: 11166453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
    Erices A; Conget P; Rojas C; Minguell JJ
    Exp Cell Res; 2002 Oct; 280(1):24-32. PubMed ID: 12372336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
    Fischer M; Goldschmitt J; Peschel C; Brakenhoff JP; Kallen KJ; Wollmer A; Grötzinger J; Rose-John S
    Nat Biotechnol; 1997 Feb; 15(2):142-5. PubMed ID: 9035138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.